Cargando…
Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria
Autores principales: | Isom, Robert, Shoor, Stanford, Higgins, John, Cara-Fuentes, Gabriel, Johnson, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732767/ https://www.ncbi.nlm.nih.gov/pubmed/31517155 http://dx.doi.org/10.1016/j.ekir.2019.05.1155 |
Ejemplares similares
-
Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
por: Angeletti, Andrea, et al.
Publicado: (2021) -
Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
por: Ainley, Louise, et al.
Publicado: (2020) -
Acute Interstitial Nephritis Triggered by a Novel Anti-CD25 Antibody-Drug Conjugate, Camidanlumab Tesirine
por: Li, Nicholas L., et al.
Publicado: (2021) -
Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab
por: Lemahieu, Wim, et al.
Publicado: (2018) -
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy”
por: Rossi, Giovanni Maria, et al.
Publicado: (2020)